Starting eculizumab as rescue therapy in refractory myasthenic crisis

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department

Jamie Roper, M. Emily Fleming, Brit Long et al. · Journal of Emergency Medicine · 2017 · 75 citations

Medicine, Emergency Medicine, Internal Medicine +14

The use of eculizumab in ventilator‐dependent myasthenia gravis patients

Uzma Usman, Christina Chrisman, Drew Houston et al. · Muscle & Nerve · 2021 · 39 citations

Life Sciences, Internal Medicine, Pharmacotherapy +10

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Generalized Myasthenia Gravis

Jonathan Monteleone, Xiang Gao, Huub Jan Kleijn et al. · Frontiers in Neurology · 2021 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19

Ulrich Hofstadt‐van Oy, Slobodan Stankovic, Corinna Kelbel et al. · Journal of Neurology · 2021 · 34 citations · Full text

Life Sciences, Immunology, Pathology +13